EP3448399A4 - Verfahren und system zur charakterisierung von hautbezogenen bedingungen - Google Patents

Verfahren und system zur charakterisierung von hautbezogenen bedingungen Download PDF

Info

Publication number
EP3448399A4
EP3448399A4 EP17790288.9A EP17790288A EP3448399A4 EP 3448399 A4 EP3448399 A4 EP 3448399A4 EP 17790288 A EP17790288 A EP 17790288A EP 3448399 A4 EP3448399 A4 EP 3448399A4
Authority
EP
European Patent Office
Prior art keywords
related conditions
skin related
characterizing skin
characterizing
conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP17790288.9A
Other languages
English (en)
French (fr)
Other versions
EP3448399A1 (de
Inventor
Zachary APTE
Jessica RICHMAN
Catalina Valdivia
Daniel Almonacid
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Psomagen Inc
Original Assignee
uBiome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by uBiome Inc filed Critical uBiome Inc
Publication of EP3448399A1 publication Critical patent/EP3448399A1/de
Publication of EP3448399A4 publication Critical patent/EP3448399A4/de
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/20—Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Data Mining & Analysis (AREA)
  • Zoology (AREA)
  • Theoretical Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Artificial Intelligence (AREA)
  • Bioethics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Evolutionary Computation (AREA)
  • Public Health (AREA)
  • Software Systems (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP17790288.9A 2016-04-25 2017-04-25 Verfahren und system zur charakterisierung von hautbezogenen bedingungen Pending EP3448399A4 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201662327089P 2016-04-25 2016-04-25
US201662327126P 2016-04-25 2016-04-25
US201662327048P 2016-04-25 2016-04-25
PCT/US2017/029470 WO2017189614A1 (en) 2016-04-25 2017-04-25 Method and system for characterizing skin related conditions

Publications (2)

Publication Number Publication Date
EP3448399A1 EP3448399A1 (de) 2019-03-06
EP3448399A4 true EP3448399A4 (de) 2020-05-13

Family

ID=60160002

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17790288.9A Pending EP3448399A4 (de) 2016-04-25 2017-04-25 Verfahren und system zur charakterisierung von hautbezogenen bedingungen

Country Status (5)

Country Link
EP (1) EP3448399A4 (de)
CN (1) CN109152803B (de)
AU (1) AU2017257785A1 (de)
CA (1) CA3022294A1 (de)
WO (1) WO2017189614A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105593372A (zh) 2013-06-18 2016-05-18 普罗皮肤检测股份有限公司 基于皮肤菌群的分析的定制皮肤护理品和个人护理品
HUE046290T2 (hu) 2016-09-13 2020-02-28 Allergan Inc Stabilizált, nem-fehérje clostridialis toxin készítmények
EP3593267A4 (de) 2017-03-10 2020-12-30 Prodermiq, Inc. Angepasste hautpflegeprodukte und körperpflegeprodukte auf basis von analysen der hautflora
CN112352058A (zh) * 2018-03-26 2021-02-09 普罗皮肤检测股份有限公司 用于治疗痤疮的组合物和方法
KR20200136423A (ko) * 2018-03-29 2020-12-07 킴벌리-클라크 월드와이드, 인크. 잠재적으로 곧 도래할 피부 또는 위장관 문제 표시 센서 및 그 사용 방법
CN117597454A (zh) * 2021-07-05 2024-02-23 联合利华知识产权控股有限公司 用于评估皮肤的方法
EP4367259A1 (de) * 2021-07-05 2024-05-15 Unilever IP Holdings B.V. Verfahren zur bewertung einer kosmetischen zusammensetzung oder komponente davon

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013142378A1 (en) * 2012-03-17 2013-09-26 The Regents Of The University Of California Fast diagnosis and personalized treatments for acne
WO2014205088A2 (en) * 2013-06-18 2014-12-24 Prodermiq Customized skin care products and personal care products based on the analysis of skin flora
WO2015070086A1 (en) * 2013-11-07 2015-05-14 The Board Of Trustees Of The Leland Stanford Junior University Cell-free nucleic acids for the analysis of the human microbiome and components thereof
WO2015112352A2 (en) * 2014-01-25 2015-07-30 uBiome, Inc. Method and system for microbiome analysis
WO2016065075A1 (en) * 2014-10-21 2016-04-28 uBiome, Inc. Method and system for microbiome-derived diagnostics and therapeutics
WO2016168350A1 (en) * 2015-04-13 2016-10-20 uBiome, Inc. Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions
WO2017156031A1 (en) * 2016-03-07 2017-09-14 uBiome, Inc. Method and system for characterizing mouth-associated conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120189621A1 (en) * 2011-01-21 2012-07-26 Yann Dean Combination Therapies and Methods Using Anti-CD3 Modulating Agents and Anti-IL-6 Antagonists
CN107936121B (zh) * 2011-05-16 2022-01-14 埃泰美德(香港)有限公司 多特异性fab融合蛋白及其使用方法
US10131710B2 (en) * 2013-01-14 2018-11-20 Xencor, Inc. Optimized antibody variable regions
EP2961770A1 (de) * 2013-02-26 2016-01-06 Roche Glycart AG Bispezifische antigenbindende moleküle zur t-zellen-aktivierung
ES2790420T3 (es) * 2013-03-14 2020-10-27 Scripps Research Inst Conjugados de anticuerpos y de agentes de focalización usos de los mismos

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013142378A1 (en) * 2012-03-17 2013-09-26 The Regents Of The University Of California Fast diagnosis and personalized treatments for acne
WO2014205088A2 (en) * 2013-06-18 2014-12-24 Prodermiq Customized skin care products and personal care products based on the analysis of skin flora
WO2015070086A1 (en) * 2013-11-07 2015-05-14 The Board Of Trustees Of The Leland Stanford Junior University Cell-free nucleic acids for the analysis of the human microbiome and components thereof
WO2015112352A2 (en) * 2014-01-25 2015-07-30 uBiome, Inc. Method and system for microbiome analysis
WO2016065075A1 (en) * 2014-10-21 2016-04-28 uBiome, Inc. Method and system for microbiome-derived diagnostics and therapeutics
WO2016168350A1 (en) * 2015-04-13 2016-10-20 uBiome, Inc. Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions
WO2017156031A1 (en) * 2016-03-07 2017-09-14 uBiome, Inc. Method and system for characterizing mouth-associated conditions

Also Published As

Publication number Publication date
WO2017189614A1 (en) 2017-11-02
CN109152803B (zh) 2022-09-23
AU2017257785A1 (en) 2018-11-08
CN109152803A (zh) 2019-01-04
EP3448399A1 (de) 2019-03-06
CA3022294A1 (en) 2017-11-02

Similar Documents

Publication Publication Date Title
EP3413221A4 (de) Risikobewertungsverfahren und -system
EP3470880A4 (de) Vermessungssystem und vermessungsverfahren
EP3264980A4 (de) System und verfahren zur patientenpositionierung
EP3179918A4 (de) System und -verfahren zur planung eines behandlungsverfahrens
EP3274967A4 (de) System und verfahren zur planung eines medizinischen verfahrens
EP3260813A4 (de) Vermessungssystem und vermessungsverfahren
EP3562399A4 (de) Bildgebungsverfahren und -system
EP3451278A4 (de) System zur erstellung eines lieferplans und verfahren zur erstellung eines lieferplans
EP3457301A4 (de) Verfahren und system zum starten einer anwendung
EP3371561A4 (de) Vorrichtung und verfahren zur personalisierten haarfärbung
EP3273648A4 (de) System und verfahren
EP3448399A4 (de) Verfahren und system zur charakterisierung von hautbezogenen bedingungen
EP3422939A4 (de) Verfahren und system zur bildgebung
EP3457666A4 (de) Verfahren und system zum starten einer anwendung
EP3217967A4 (de) System und verfahren zur verhinderung von alopezie
EP3311524A4 (de) System und verfahren zur abdeckungserweiterung
EP3105965A4 (de) System und verfahren zum rehoming von verbindungen
EP3692009A4 (de) Biozementationsverfahren und system
EP3464673A4 (de) Lochmaskenablagerungssystem und verfahren dafür
EP3318972A4 (de) System zur bereitstellung einer anwendungsliste und verfahren dafür
EP3437079A4 (de) Verfahren und system zur überwachung
EP3590725A4 (de) Mediumausgabesystem und mediumausgabeverfahren
EP3426794A4 (de) Verfahren und system zur charakterisierung von mundassoziierten bedingungen
IL266455A (en) System and method for creating tissue
EP3355685A4 (de) Bewässerungsverfahren und -system

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20181024

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61K0035740000

Ipc: C12Q0001689000

A4 Supplementary search report drawn up and despatched

Effective date: 20200417

RIC1 Information provided on ipc code assigned before grant

Ipc: G06F 17/00 20190101ALI20200408BHEP

Ipc: C12Q 1/689 20180101AFI20200408BHEP

19U Interruption of proceedings before grant

Effective date: 20191011

19W Proceedings resumed before grant after interruption of proceedings

Effective date: 20201201

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: PSOMAGEN, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230905